Profile change history

What changed for Efpeglenatide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Efpeglenatide identity.

7Total events
7Record additions
0Version changes
4Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 7 connected records →

Showing the latest 7 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT01093729

PeptideScanner retained ClinicalTrials.gov record NCT01093729 at 2026-11-16T17:34:46.889Z. Its registry update date was 2014-02-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.

PeptideScanner change date
November 16, 2026
Cited source date
February 7, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01452451

PeptideScanner retained ClinicalTrials.gov record NCT01452451 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.

PeptideScanner change date
November 16, 2026
Cited source date
August 9, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02075281

PeptideScanner retained ClinicalTrials.gov record NCT02075281 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.

PeptideScanner change date
November 16, 2026
Cited source date
August 9, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02081118

PeptideScanner retained ClinicalTrials.gov record NCT02081118 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.

PeptideScanner change date
November 16, 2026
Cited source date
August 9, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06174779

PeptideScanner retained ClinicalTrials.gov record NCT06174779 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.

PeptideScanner change date
November 16, 2026
Cited source date
July 7, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07379333

PeptideScanner retained ClinicalTrials.gov record NCT07379333 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-05-13, and PeptideScanner's reviewed identity mapping was efpeglenatide.

PeptideScanner change date
November 16, 2026
Cited source date
May 13, 2026
Evidence lane
Clinical trials
Record added

Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes.

PubMed lists PMID 41403449 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2025-12-01 (day precision). PeptideScanner associated the retained record with the identity slug efpeglenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 19, 2025
Evidence lane
Literature metadata